Thrivent Financial for Lutherans’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-42,887
| Closed | -$1.69M | – | 2388 |
|
|
2024
Q4 | $1.69M | Sell |
42,887
-4,809
| -10% | -$189K | ﹤0.01% | 1566 |
|
|
2024
Q3 | $2.24M | Buy |
47,696
+473
| +1% | +$22.2K | ﹤0.01% | 1359 |
|
|
2024
Q2 | $2.55M | Buy |
47,223
+16,051
| +51% | +$867K | 0.01% | 1235 |
|
|
2024
Q1 | $2.13M | Sell |
31,172
-6,751
| -18% | -$460K | ﹤0.01% | 1367 |
|
|
2023
Q4 | $2.37M | Buy |
37,923
+4,137
| +12% | +$259K | 0.01% | 1271 |
|
|
2023
Q3 | $1.53M | Sell |
33,786
-15,017
| -31% | -$682K | ﹤0.01% | 1476 |
|
|
2023
Q2 | $2.74M | Sell |
48,803
-401
| -0.8% | -$22.5K | 0.01% | 1138 |
|
|
2023
Q1 | $2.23M | Sell |
49,204
-29,612
| -38% | -$1.34M | 0.01% | 1230 |
|
|
2022
Q4 | $3.2M | Buy |
78,816
+53,608
| +213% | +$2.18M | 0.01% | 973 |
|
|
2022
Q3 | $1.65M | Buy |
25,208
+4,144
| +20% | +$271K | ﹤0.01% | 1339 |
|
|
2022
Q2 | $1.28M | Buy |
21,064
+9,382
| +80% | +$570K | ﹤0.01% | 1545 |
|
|
2022
Q1 | $733K | Sell |
11,682
-28,702
| -71% | -$1.8M | ﹤0.01% | 2006 |
|
|
2021
Q4 | $3.4M | Buy |
40,384
+38,516
| +2,062% | +$3.24M | 0.01% | 1070 |
|
|
2021
Q3 | $209K | Sell |
1,868
-2,088
| -53% | -$234K | ﹤0.01% | 2420 |
|
|
2021
Q2 | $640K | Buy |
3,956
+1,373
| +53% | +$222K | ﹤0.01% | 2092 |
|
|
2021
Q1 | $315K | Buy |
+2,583
| New | +$315K | ﹤0.01% | 2377 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2365 |
|